TR-987
Chronic wounds
Phase 2BCompleted
Key Facts
About Tissue Repair
Australian‑based biotech leveraging beta‑glucan immunomodulation to treat wounds and enhance aesthetic recovery.
View full company profileTherapeutic Areas
Other Chronic wounds Drugs
| Drug | Company | Phase |
|---|---|---|
| Tuned Stem Cell EVs for Chronic Wounds | ZenBio | Pre-clinical |